Purified adenoviral compositions
AssigneeIntrogen Therapeutics, Inc.
InventorsShuyuan Zhang, Capucine Thwin, Zheng Wu, Toohyon Cho, Deborah R. Wilson, Lucetta Caston
Life of this patent
Estimating the term…
Loading patent…
AssigneeIntrogen Therapeutics, Inc.
InventorsShuyuan Zhang, Capucine Thwin, Zheng Wu, Toohyon Cho, Deborah R. Wilson, Lucetta Caston
Estimating the term…
The present invention addresses the need to improve the yields of viral vectors when grown in cell culture systems. In particular, it has been demonstrated that for adenovirus, the use of low-medium perfusion rates in an attached cell culture system provides for improved yields. In other embodiments, the inventors have shown that there is improved Ad-p53 production witrh cells grown in serum-free conditions, and in particular in serum-free suspension culture. Also important to the increase of yields is the use of detergent lysis. Combination of these aspects of the invention permits purification of virus by a single chromatography step that results in purified virus of the same quality as preparations from double CsCl banding using an ultracentrifuge.
A purified adenovirus composition, the composition having a contaminating nucleic acid content of less than 400 pg per 1010 pfu virus and greater than or equal to about 60 pg per 1010 pfu virus.
A purified adenovirus composition having (a) a level of BSA that is essentially undetectable by Western blot analysis;
Dependencies are inferred from the claim text.